Trials / Completed
CompletedNCT02470910
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning: A Pilot Study to Quantitate the Potential to Limit Radiation Dose to Normal Tissues.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study is evaluating whether a standard prostate MRI examination can improve radiation therapy planning for prostate cancer.
Detailed description
In this research study, the investigators want to determine if prostate radiotherapy treatment planning can be improved by using an MRI scan to help doctors more accurately target the prostate with radiation and decrease radiation dose to the rectum, which is just behind the prostate. To do this, the investigators will create a treatment plan based on the MRI scan and compare it to the standard treatment, which currently uses a CT scan rather than an MRI. The results of this study will help inform doctors whether it is beneficial to routinely use an MRI scan for prostate radiotherapy treatment planning.
Conditions
- Prostate Cancer
- Adenocarcinoma of the Prostate Stage I
- Adenocarcinoma of the Prostate Stage II
- Adenocarcinoma of the Prostate Stage III
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetic Resonance Imaging |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2018-07-01
- Completion
- 2018-07-01
- First posted
- 2015-06-12
- Last updated
- 2019-12-11
- Results posted
- 2019-11-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02470910. Inclusion in this directory is not an endorsement.